文献速递中毒与环境急症复苏、休克与脓毒症重症综合管理与镇静镇痛

两例叠氮化钠中毒死亡:延迟的增强清除无效

Two fatalities from sodium azide ingestion: delayed enhanced elimination was not effective.
PubMed 文献 · Clin Toxicol (Phila) · 2025-07-30
一句话结论摄入至少2 g叠氮化钠后,即使进行增强清除(血液透析或血浆置换),两名患者仍死于难治性休克。

本文报告两例叠氮化钠中毒死亡病例。第一例27岁男性摄入约5 g叠氮化钠,1小时后出现低血压,予洗胃和血管升压药,13小时后行血液透析,仍反复心脏骤停死亡。第二例19岁男性摄入40 mL 5%(2 g)叠氮化钠,2小时后就诊,予血管升压药和血浆置换,升压药需求一度减少,但休克复发最终死亡。作者认为延迟启动血液透析和血浆置换可能限制了潜在获益,增强清除似乎未改变摄入至少2 g叠氮化钠患者的毒性病程。

要点

  • 摄入至少2 g叠氮化钠可导致难治性休克和死亡,两例患者均死于毒性。
  • 第一例摄入约5 g,1小时后低血压,13小时后才行血液透析,仍反复心脏骤停死亡。
  • 第二例摄入2 g,2小时后就诊,血浆置换后升压药需求一度减少,但休克复发死亡。
  • 作者认为延迟启动血液透析和血浆置换可能限制了潜在获益。
  • 增强清除似乎未改变摄入至少2 g叠氮化钠患者的毒性病程。

适用人群与场景

  • 摄入叠氮化钠的患者,两例分别为27岁男性和19岁男性。
  • 第一例摄入约5 g叠氮化钠,第二例摄入40 mL 5%(2 g)叠氮化钠。

处置流程与药物剂量

  • 第一例:摄入约5 g叠氮化钠后1小时出现低血压,行洗胃并启动血管升压药,摄入后13小时行血液透析。
  • 第二例:摄入40 mL 5%(2 g)叠氮化钠后2小时就诊,启动血管升压药并行血浆置换,之后升压药需求减少。

红旗征与不能漏的情况

  • 摄入叠氮化钠后1小时出现低血压。
  • 难治性休克,对支持治疗无反应。
  • 反复心脏骤停。
  • 血浆置换后休克复发。

研究设计与关键结果

  • 两例叠氮化钠中毒死亡病例报告:第一例27岁男性摄入约5 g,1小时后低血压,予洗胃和血管升压药,13小时后血液透析,仍反复心脏骤停死亡。
  • 第二例19岁男性摄入40 mL 5%(2 g),2小时后就诊,予血管升压药和血浆置换,升压药需求减少后休克复发,最终死亡。
  • 作者认为延迟启动血液透析和血浆置换可能限制了潜在获益。
  • 增强清除似乎未改变摄入至少2 g叠氮化钠患者的毒性病程。

证据类型、等级与局限

  • 证据类型:病例报告(两例)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为延迟启动血液透析和血浆置换可能限制了潜在获益。
  • 作者结论:增强清除似乎未改变摄入至少2 g叠氮化钠患者的毒性病程。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Ingestion of sodium azide can lead to severe toxicity, including the development of refractory shock. No antidote has been identified. Enhanced elimination has demonstrated variable outcomes in prior reports.

CASE REPORTS: We present two fatal cases of sodium azide toxicity. The first patient, a 27-year-old man, ingested approximately 5 g of sodium azide and developed hypotension 1 h after ingestion. Orogastric lavage was performed, and vasopressors were started. Hemodialysis was performed 13 h after ingestion. Despite stabilization, he developed recurrent cardiac arrest and died. The second patient, a 19-year-old man, presented 2 h after the intentional ingestion of 40 mL of 5% (2 g) sodium azide. This patient was started on vasopressors and had plasma exchange performed, after which vasopressor requirements were reduced. Shortly after, however, the patient experienced recrudescence of shock and ultimately succumbed to toxicity.

DISCUSSION: Despite aggressive supportive measures, decompensation refractory to supportive measures occurred in both patients. Enhanced elimination techniques were attempted, albeit not immediately, and the delay in initiating hemodialysis and plasma exchange may have limited any potential benefit.

CONCLUSIONS: Enhanced elimination did not appear to alter the course of toxicity in these two patients who ingested at least 2 g of sodium azide.

来源:Clin Toxicol (Phila),查看原文。版权归原作者所有。

参考来源

  1. Husak N, Sidlak A, Westover R, et al. Two fatalities from sodium azide ingestion: delayed enhanced elimination was not effective. Clin Toxicol (Phila). 2025. PMID: 40736993. doi:10.1080/15563650.2025.2528995

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。